Altering mitochondrial function and biogenesis by increasing ROS production generates more inflammation, promoting increased activity of NLRP3 (pyrin domain of the Nod 3-like receptor family) that participates in sarcopenia [54,62,63,64]. Here, MEFV is linked to sarcopenia.